Altered in vitro endothelial repair and Monocyte migration in obstructive sleep apnea: Implication of VEGF and CRP

Sleep

Volumn 37, Issue 11, 2014, Pages 1825-1832B

  Briançon Marjollet, Anne ^a,b   Henri, Marion ^a,b   Pépin, Jean Louis ^a,b,c   Lemarié, Emeline ^a,b   Lévy, Patrick ^a,b,c   Tamisier, Renaud ^a,b,c  

^a UNIV GRENOBLE ALPES   (France)

^b University Grenoble Alpes   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Endothelial repair; HsCRP; Metabolic syndrome; Obstructive sleep apnea; VEGF

Indexed keywords

BLOCKING ANTIBODY; C REACTIVE PROTEIN; VASCULOTROPIN; VASCULOTROPIN A;

ADULT; ARTICLE; ATHEROSCLEROSIS; CASE CONTROL STUDY; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MONOCYTE; PROTEIN BLOOD LEVEL; SLEEP DISORDERED BREATHING; WOUND HEALING; ANOXIA; ANTAGONISTS AND INHIBITORS; BLOOD; CELL LINE; CELL MOTION; COMPLICATION; DRUG EFFECTS; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY;

ANOXIA; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CELL LINE; CELL MOVEMENT; ENDOTHELIAL CELLS; FEMALE; HUMANS; IN VITRO TECHNIQUES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MONOCYTES; SLEEP APNEA, OBSTRUCTIVE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 84908402118     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.4180     Document Type: Article

References (39)

1. Baguet JP, Barone-Rochette G, Tamisier R, Levy P, Pepin JL. Mechanisms of cardiac dysfunction in obstructive sleep apnea. Nat Rev Cardiol 2010;9:679-88.
2. Levy P, Pepin JL, Arnaud C, et al. Intermittent hypoxia and sleepdisordered breathing: current concepts and perspectives. Eur Respir J 2008;32:1082-95.
3. Arnaud C, Dematteis M, Pepin JL, Baguet JP, Levy P. Obstructive sleep apnea, immuno-inflammation, and atherosclerosis. Semin Immunopathol 2009;31:113-25.
4. Levy P, Pepin JL, Arnaud C, Baguet JP, Dematteis M, Mach F. Obstructive sleep apnea and atherosclerosis. Prog Cardiovasc Dis 2009;51:400-10.
5. McNicholas WT. Obstructive sleep apnea and inflammation. Prog Cardiovasc Dis 2009;51:392-9.
6. VanderLaan PA, Reardon CA, Getz GS. Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators. Arterioscler Thromb Vasc Biol 2004;24:12-22.
7. Chiu JJ, Chien S. Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiol Rev 2011;91:327-87.
8. Dematteis M, Julien C, Guillermet C, et al. Intermittent hypoxia induces early functional cardiovascular remodeling in mice. Am J Respir Crit Care Med 2008;177:227-35.
9. Hsu PP, Li S, Li YS, et al. Effects of flow patterns on endothelial cell migration into a zone of mechanical denudation. Biochem Biophys Res Commun 2001;285:751-9.
10. Hagensen MK, Raarup MK, Mortensen MB, et al. Circulating endothelial progenitor cells do not contribute to regeneration of endothelium after murine arterial injury. Cardiovasc Res 2012; 93:223-31.
11. Mullick AE, Soldau K, Kiosses WB, Bell TA 3rd, Tobias PS, Curtiss LK. Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events. J Exp Med 2008;205:373-83.
12. Xu Q. Disturbed flow-enhanced endothelial turnover in atherosclerosis. Trends Cardiovasc Med 2009;19:191-5.
13. Atkeson A, Yeh SY, Malhotra A, Jelic S. Endothelial function in obstructive sleep apnea. Prog Cardiovasc Dis 2009;51:351-62.
14. Feng J, Zhang D, Chen B. Endothelial mechanisms of endothelial dysfunction in patients with obstructive sleep apnea. Sleep Breath 2012;16:283-94.
15. Jelic S, Padeletti M, Kawut SM, et al. Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation. 2008;117:2270-8.
16. Imagawa S, Yamaguchi Y, Higuchi M, Neichi T, Hasegawa Y, Mukai HY, et al. Levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea-hypopnea syndrome. Blood 2001;98:1255-7.
17. Lavie L, Kraiczi H, Hefetz A, et al. Plasma vascular endothelial growth factor in sleep apnea syndrome: effects of nasal continuous positive air pressure treatment. Am J Respir Crit Care Med 2002;165:1624-8.
18. Gozal D, Lipton AJ, Jones KL. Circulating vascular endothelial growth factor levels in patients with obstructive sleep apnea. Sleep 2002;25:59-65.
19. Schulz R, Hummel C, Heinemann S, Seeger W, Grimminger F. Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia. Am J Respir Crit Care Med 2002;165:67-70.
20. Teramoto S, Kume H, Yamamoto H, et al. Effects of oxygen administration on the circulating vascular endothelial growth factor (VEGF) levels in patients with obstructive sleep apnea syndrome. Intern Med 2003;42:681-5.
21. Schneeweis C, Grafe M, Bungenstock A, Spencer-Hansch C, Fleck E, Goetze S. Chronic CRP-exposure inhibits VEGF-induced endothelial cell migration. J Atheroscler Thromb 2010;17:203-12.
22. Montecucco F, Steffens S, Burger F, Pelli G, Monaco C, Mach F. C-reactive protein (CRP) induces chemokine secretion via CD11b/ ICAM-1 interaction in human adherent monocytes. J Leukoc Biol 2008;84:1109-19.
23. Lui MM, Sau-Man M. OSA and atherosclerosis. J Thorac Dis 2012;4:164-72.
24. Taheri S, Austin D, Lin L, Nieto FJ, Young T, Mignot E. Correlates of serum C-reactive protein (CRP)-no association with sleep duration or sleep disordered breathing. Sleep 2007;30:991-6.
25. Bonsignore MR, McNicholas WT, Montserrat JM, Eckel J. Adipose tissue in obesity and obstructive sleep apnoea. Eur Respir J 2012;39:746-67.
26. Jun J, Polotsky VY. Metabolic consequences of sleep-disordered breathing. ILAR J 2009;50:289-306.
27. Pepin JL, Tamisier R, Levy P. Obstructive sleep apnoea and metabolic syndrome: put CPAP efficacy in a more realistic perspective. Thorax 2012;67:1025-7.
28. Peled N, Shitrit D, Bendayan D, Peled E, Kramer MR. Association of elevated levels of vascular endothelial growth factor in obstructive sleep apnea syndrome with patient age rather than with obstructive sleep apnea syndrome severity. Respiration 2007;74:50-5.
29. Schwartz R, Osborne-Lawrence S, Hahner L, et al. C-reactive protein downregulates endothelial NO synthase and attenuates reendothelialization in vivo in mice. Circ Res 2007;100:1452-9.
30. Carreras A, Rojas M, Tsapikouni T, Montserrat JM, Navajas D, Farre R. Obstructive apneas induce early activation of mesenchymal stem cells and enhancement of endothelial wound healing. Respir Res 2010;11:91.
31. Van der Heiden K, Gijsen FJ, Narracott A, et al. The effects of stenting on shear stress: relevance to endothelial injury and repair. Cardiovasc Res 2013;99:269-75.
32. Hrynkiewicz-Szymanska A, Szymanski FM, Filipiak KJ, et al. Can obstructive sleep apnea be a cause of in-stent thrombosis? Sleep Breath 2011;15:607-9.
33. Montecucco F, Burger F, Pelli G, et al. Statins inhibit C-reactive proteininduced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes. Rheumatology (Oxford) 2009;48:233-42.
34. Devaraj S, Du Clos TW, Jialal I. Binding and internalization of C-reactive protein by Fcgamma receptors on human aortic endothelial cells mediates biological effects. Arterioscler Thromb Vasc Biol 2005;25::1359-63.
35. Iber C, Ancoli-Israel S, Chesson A, Quan SF. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. 1st ed. Westchester, IL: American Academy of Sleep Medicine, 2007.
36. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999; 22: 667-89.
37. Berry RB, Budhiraja R, Gottlieb DJ, et al. Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med 2012; 8: 597-619.
38. Argod J, Pepin JL, Levy P. Differentiating obstructive and central sleep respiratory events through pulse transit time. Am J Respir Crit Care Med 1998; 158: 1778-83.
39. Hosselet JJ, Norman RG, Ayappa I, Rapoport DM. Detection of flow limitation with a nasal cannula/pressure transducer system. Am J Respir Crit Care Med 1998; 157: 1461-7.